First participant dosed in Terns’ trial of TERN-601 oral GLP-1ra for treatment of obesity
Terns Pharmaceuticals has announced that the first participant has been dosed in the Phase 1 clinical trial of TERN-601, the company’s...
top of page
Browse by category
Search
Browse by tag
bottom of page